Cargando…

Novel Scaffolds for Modulation of NOD2 Identified by Pharmacophore-Based Virtual Screening

Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is an innate immune pattern recognition receptor responsible for the recognition of bacterial peptidoglycan fragments. Given its central role in the formation of innate and adaptive immune responses, NOD2 represents a valuable tar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guzelj, Samo, Tomašič, Tihomir, Jakopin, Žiga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405794/ https://www.ncbi.nlm.nih.gov/pubmed/36008948 http://dx.doi.org/10.3390/biom12081054

Ejemplares similares

Discovery of Desmuramylpeptide NOD2 Agonists with Single-Digit Nanomolar Potency
por: Guzelj, Samo, et al.
Publicado: (2022)

Covalently Conjugated NOD2/TLR7 Agonists Are Potent and Versatile Immune Potentiators
por: Guzelj, Samo, et al.
Publicado: (2022)

Lipidation of NOD2 Agonists with Adamantane and Stearoyl Moieties Differentially Regulates Their In Vivo Adjuvant Activity
por: Guzelj, Samo, et al.
Publicado: (2022)

Synthesis of Conformationally Constrained d-Glu-meso-DAP Analogs as Innate Immune Agonists
por: Guzelj, Samo, et al.
Publicado: (2020)

Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagement Promotes Non-Specific Immune Response Against K562 Cancer Cells
por: Guzelj, Samo, et al.
Publicado: (2022)

Novel scaffolds for modulation of TRPV1 identified with pharmacophore modeling and virtual screening
por: Goldmann, Daria, et al.
Publicado: (2015)

Structure-Guided Design of d-Galactal Derivatives with High Affinity and Selectivity for the Galectin-8 N-Terminal Domain
por: Hassan, Mujtaba, et al.
Publicado: (2021)

Structural Fine-Tuning of Desmuramylpeptide NOD2 Agonists Defines Their In Vivo Adjuvant Activity
por: Guzelj, Samo, et al.
Publicado: (2021)

THP-1 Cells and Pro-Inflammatory Cytokine Production: An In Vitro Tool for Functional Characterization of NOD1/NOD2 Antagonists
por: Jakopin, Žiga, et al.
Publicado: (2019)

Design and synthesis of novel 3-triazolyl-1-thiogalactosides as galectin-1, -3 and -8 inhibitors
por: van Klaveren, Sjors, et al.
Publicado: (2022)

Selective DNA Gyrase Inhibitors: Multi-Target in Silico Profiling with 3D-Pharmacophores
por: Tomašič, Tihomir, et al.
Publicado: (2021)

Non-Extensive Fragmentation of Natural Products and Pharmacophore-Based Virtual Screening as a Practical Approach to Identify Novel Promising Chemical Scaffolds
por: Vásquez, Andrés Felipe, et al.
Publicado: (2021)

Combination of Docking-Based and Pharmacophore-Based Virtual Screening Identifies Novel Agonists That Target the Urotensin Receptor
por: Li, Na, et al.
Publicado: (2022)

Pharmacophore Models and Pharmacophore-Based Virtual Screening: Concepts and Applications Exemplified on Hydroxysteroid Dehydrogenases
por: Kaserer, Teresa, et al.
Publicado: (2015)

Ligand-based pharmacophore modeling, virtual screening and biological evaluation to identify novel TGR5 agonists
por: Zhao, Shizhen, et al.
Publicado: (2021)

Discovery of Potential M2 Channel Inhibitors Based on the Amantadine Scaffold via Virtual Screening and Pharmacophore Modeling
por: Tran, Linh, et al.
Publicado: (2011)

Molecular Dynamics-Derived Pharmacophore Model Explaining the Nonselective Aspect of K(V)10.1 Pore Blockers
por: Toplak, Žan, et al.
Publicado: (2021)

Probabilistic Approach for Virtual Screening Based on Multiple Pharmacophores
por: Madzhidov, Timur I., et al.
Publicado: (2020)

Pharmacophore Based Virtual Screening Approach to Identify Selective PDE4B Inhibitors
por: Gaurav, Anand, et al.
Publicado: (2017)

Pharmacophore-Based Virtual Screening Toward the Discovery of Novel Anti-echinococcal Compounds
por: Liu, Congshan, et al.
Publicado: (2020)

Pharmacophore-Model-Based Virtual-Screening Approaches Identified Novel Natural Molecular Candidates for Treating Human Neuroblastoma
por: Opo, F A Dain Md, et al.
Publicado: (2022)

Discovery of Novel Hsp90 C-Terminal Inhibitors Using 3D-Pharmacophores Derived from Molecular Dynamics Simulations
por: Tomašič, Tihomir, et al.
Publicado: (2020)

3D Pharmacophore-Based Discovery of Novel K(V)10.1 Inhibitors with Antiproliferative Activity
por: Toplak, Žan, et al.
Publicado: (2021)

Pharmacophore and Virtual Screening of JAK3 inhibitors
por: Rajeswari, Murugesan, et al.
Publicado: (2014)

Drug Design by Pharmacophore and Virtual Screening Approach
por: Giordano, Deborah, et al.
Publicado: (2022)

Pharmacophore-Based Virtual Screening and Molecular Dynamics Simulation for Identification of a Novel DNA Gyrase B Inhibitor with Benzoxazine Acetamide Scaffold
por: Elseginy, Samia A., et al.
Publicado: (2021)

Application of ensemble pharmacophore-based virtual screening to the discovery of novel antimitotic tubulin inhibitors
por: Gallego-Yerga, Laura, et al.
Publicado: (2021)

Ligand Based Pharmacophore Modeling and Virtual Screening Studies to Design Novel HDAC2 Inhibitors
por: Kandakatla, Naresh, et al.
Publicado: (2014)

Pharmacophore‐guided Virtual Screening to Identify New β(3)‐adrenergic Receptor Agonists
por: Ujiantari, Navista Sri Octa, et al.
Publicado: (2022)

Combining docking with pharmacophore filtering for improved virtual screening
por: Peach, Megan L, et al.
Publicado: (2009)

Discovery of YopE Inhibitors by Pharmacophore-Based Virtual Screening and Docking
por: Ozbuyukkaya, Gizem, et al.
Publicado: (2013)

Discovery of Novel TASK-3 Channel Blockers Using a Pharmacophore-Based Virtual Screening
por: Ramírez, David, et al.
Publicado: (2019)

Identification of novel acetylcholinesterase inhibitors designed by pharmacophore-based virtual screening, molecular docking and bioassay
por: Jang, Cheongyun, et al.
Publicado: (2018)

Structure-Based Pharmacophore Design and Virtual Screening for Novel Tubulin Inhibitors with Potential Anticancer Activity
por: Zhou, Yunjiang, et al.
Publicado: (2019)

Pharmacophore and docking-based sequential virtual screening for the identification of novel Sigma 1 receptor ligands
por: Alamri, Mubarak A, et al.
Publicado: (2019)

Identification of Novel Mitochondrial Pyruvate Carrier Inhibitors by Homology Modeling and Pharmacophore-Based Virtual Screening
por: Hegazy, Lamees, et al.
Publicado: (2022)

Iron-Binding and Anti-Fenton Properties of Novel Amino Acid-Derived Cyclic Imide Dioximes
por: Mravljak, Janez, et al.
Publicado: (2019)

Pharmacophore-based virtual screening approaches to identify novel molecular candidates against EGFR through comprehensive computational approaches and in-vitro studies
por: Opo, F A Dain Md, et al.
Publicado: (2022)

Identification of Novel HBV/HDV Entry Inhibitors by Pharmacophore- and QSAR-Guided Virtual Screening
por: Kirstgen, Michael, et al.
Publicado: (2021)

Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Discovery of Novel Akt2 Inhibitors
por: Fei, Jia, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_33jtf4big9jjmfihdsmcupg5mp